CBR1 Rabbit monoclonal antibody

• Background:

  NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol.

• Structure Composition:

  Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2.

• Product Name Alternative:

  15 hydroxyprostaglandin dehydrogenase [NADP+]; Carbonyl reductase [NADPH] 1; CBR1; CRN; NADPH dependent carbonyl reductase 1; Prostaglandin 9 ketoreductase; SDR21C1

• Swiss Prot:

  P16152

• Reactivity:

  Human

• Immunogen:

  A synthesized peptide derived from human CBR1

• Conjugation:

  Unconjugated

• Applications:

  WB IHC ICC/IF

• Dilution:

  WB 1:500~1:2000 IHC 1:50~1:200 ICC/IF 1:50~1:200

• Purity:

  Affinity-chromatography

• Modification:

  Unmodified

• Molecular Weight:

  30kDa

• Storage Conditions:

  Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

• Notes:

  For research use only, not for use in diagnostic procedure.

• Specificity:

  CBR1 Antibody detects endogenous levels of total CBR1

• Applications Notes:

  Western blot analysis of CBR1 expression in HeLa cell lysate.

• Host or Source:

  Rabbit

• CAS Number:

  9007-83-4